MicrofluidX

MicrofluidX provides next-generation bioreactors for cell research and manufacturing.

Stevenage, UK—Website

£4.7MTotal raised

MicrofluidX develops next-generation bioreactors and scalable cell culture platforms for advanced research and manufacturing.

Antoine Espinet

CEO

Series A8 December 2022

£3.3M

The Stevenage enterprise raised the capital from Longwall Ventures and a syndicate of backers to fund trials and product development.

Seed20 April 2020

£1.4M

The seed round was led by UKI2S and Longwall Ventures to support cell therapy bioprocessing development.